Julia Tutzauer

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Forskningsbeskrivning

Hormonbehandlingsresistens inom bröstcancer

Artiklar

Journal article: ANNALS OF ONCOLOGY. 2024;35:s340
300P Gene expression landscape of the long-term tamoxifen resistance in premenopausal ER+ breast cancer patients in the STO-5 controlled randomized clinical trial with >20-year follow-up
Tutzauer J; De Vos JKJ; Nordenskjöld A; Nordenskjöld BA; Fornander T; Tenorio GP; Stål O; Tobin NP; Lindström LS
Journal article: ANNALS OF ONCOLOGY. 2024;35:s390
409P Biological tumor traits predicting late recurrence in premenopausal breast cancer patients: Insights from the STO-5 trial with 20-year follow-up
De Vos JKJ; Tutzauer J; Nordenskjöld A; Nordenskjöld BA; Fornander T; Tenorio GP; Stål O; Tobin NP; Lindström LS
Journal article: CANCER RESEARCH. 2024;84(9):po4-05-14-po4-05-14
Gene expression in metastatic breast cancer - patterns and prognostic potential
Tutzauer J; Larsson A-M; Aaltonen K; Bendahl P-O; Bergenfelz C; Jorgensen CLT; Ryden L
Journal article: ACTA ONCOLOGICA. 2024;63(1):125-136
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
Engstrom T; Ekholm M; Ferno M; Lundgren C; Nordenskjold B; Stal O; Bendahla P-O; Tutzauer J; Ryden L
Journal article: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2024;752:109882
G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the 81-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells
Tutzauer J; Serafin DS; Schmidt T; Olde B; Serafin S; Caron KM; Leeb-Lundberg LMF
Journal article: BREAST CANCER RESEARCH. 2023;25(1):110
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Lundgren C; Tutzauer J; Church SE; Stal O; Ekholm M; Forsare C; Nordenskjold B; Ferno M; Bendahl P-O; Ryden L
Journal article: FRONTIERS IN MOLECULAR BIOSCIENCES. 2023;10:1343979
Gene expression in metastatic breast cancer-patterns in primary tumors and metastatic tissue with prognostic potential
Tutzauer J; Larsson A-M; Aaltonen K; Bergenfelz C; Bendahl P-O; Ryden L
Journal article: BRITISH JOURNAL OF CANCER. 2022;126(8):1145-1156
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up
Tutzauer J; Sjostrom M; Holmberg E; Karlsson P; Killander F; Leeb-Lundberg LMF; Malmstrom P; Nimeus E; Ferno M; Jogi A
Journal article: MOLECULAR PHARMACOLOGY. 2021;100(3):271-282
Ligand-Independent G Protein-Coupled Estrogen Receptor/G Protein-Coupled Receptor 30 Activity: Lack of Receptor-Dependent Effects of G-1 and 17β-Estradiol.
Tutzauer J; Gonzalez de Valdivia E; Swärd K; Alexandrakis Eilard I; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
Journal article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(10):5250
Mast Cell Proteases Tryptase and Chymase Induce Migratory and Morphological Alterations in Bronchial Epithelial Cells
Berlin F; Mogren S; Tutzauer J; Andersson CK
Journal article: CANCER RESEARCH. 2020;80(4):p6-05-09-p6-05-09
G protein-coupled estrogen receptor expressed in the plasma membrane is associated with worse breast cancer outcome, but does not contribute to tamoxifen resistance
Tutzauer J; Sjostrom M; Bendahl P-O; Ryden L; Ferno M; Leeb-Lundberg F; Alkner S
Journal article: PLOS ONE. 2020;15(4):e0231786
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
Tutzauer J; Sjostrom M; Bendahl P-O; Ryden L; Ferno M; Leeb-Lundberg LMF; Alkner S

Anställningar

Postdoktor, Onkologi-Patologi, Karolinska Institutet, 2024-2026
Postdokforskare, Onkologi - bröstcancer, Institutionen för kliniska vetenskaper, Lunds Universitet, 2022-2023

Examina och utbildning

Doktorstitel i molekylär farmakologi, biomedicin, Biomedicin, GPR30 in breast cancer - from molecular mechanisms to clinical outcome, Avdelningen för Experimentell Medicinsk Vetenskap, Lunds Universitet, 2022

Forskningsbeskrivning

Artiklar

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI